Atul Ltd
NSE: ATUL · Specialty Chemicals · sector
Key numbers
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 107 companies in Specialty Chemicals (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹1,743 cr vs borrowings ₹180 cr (FY26): cash is higher (net cash).
- Operating profit covered interest 64.0x in the last 12 months.
- 0.97% of the promoters' shares are pledged (0.4% of all shares).
- Operating cash flow was below net profit in 1 of the last 4 years (FY22).
- Revenue was higher than a year earlier in 4 of the last 4 quarters.
- Other income was 30% of net profit in the last 12 months.
- Debtor days went from 57 (FY23) to 74 (FY26).
- Dividend paid in 4 of the last 5 financial years.
- Price ₹5,354.00 on 2026-10-26: -25.4% from the 52-week high, 0.0% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,393 | 1,417 | 1,452 | 1,478 | 1,552 | 1,574 | 1,670 | 1,848 |
| EBITDA | 243 | 224 | 223 | 236 | 267 | 247 | 283 | 394 |
| OPM % | 17.4% | 15.8% | 15.4% | 15.9% | 17.2% | 15.7% | 16.9% | 21.3% |
| Other income | 32 | 16 | 49 | 26 | 48 | 39 | 90 | 33 |
| Net profit | 137 | 109 | 126 | 128 | 88 | 161 | 210 | 245 |
| EPS (₹) | 46.47 | 36.93 | 42.97 | 43.40 | 60.88 | 54.60 | 71.38 | 83.32 |
| Revenue YoY | +11.4% | +11.1% | +15.0% | +25.0% | ||||
| Profit YoY | -35.7% | +47.8% | +66.1% | +92.0% |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY21 | FY22 | FY23 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 3,731 | 4,993 | 5,428 | 5,583 | 6,274 | 6,643 |
| EBITDA | 917 | 863 | 779 | 913 | 1,037 | 1,191 |
| Net profit | 76 | 608 | -89 | 484 | 678 | 704 |
| EPS (₹) | 221.17 | 205.34 | 174.15 | 164.37 | 230.25 | 270.18 |
| Revenue growth | +33.8% | +8.7% | +2.9% | +12.4% | +15.8% | |
| Profit growth | +699.0% | -114.6% | – | +40.1% | +40.9% | |
| Dividend / share (₹) | – | 20.00 | 32.50 | 20.00 | 25.00 |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +7.9% | – | +15.8% |
| Net profit | +3.7% | – | +40.9% |
| EPS | +3.9% | – | – |
| Share price | – | -11.0% (2y) | +0.4% |
Balance sheet
| ₹ cr | FY22 | FY23 | FY25 | FY26 |
|---|---|---|---|---|
| Shareholders' equity | – | 4,671 | 5,599 | 6,222 |
| Borrowings | – | 47 | 198 | 180 |
| Cash & equivalents | – | 242 | 881 | 1,743 |
| Total assets | – | 5,768 | 7,001 | 7,900 |
| Fixed assets | – | 1,714 | 2,792 | 2,619 |
| Capital work in progress | – | 1,033 | 124 | 110 |
| Investments | – | 649 | 893 | 887 |
| Receivables | – | 845 | 1,126 | 1,271 |
| Inventory | – | 789 | 729 | 815 |
| Payables | – | 539 | 615 | 852 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY22 | FY23 | FY25 | FY26 |
|---|---|---|---|---|
| Cash from operations | 217 | 707 | 603 | 1,023 |
| Cash from investing | -225 | -469 | -495 | -895 |
| Cash from financing | 11 | -257 | -84 | -98 |
| Capex | 297 | 875 | 270 | 175 |
| Free cash flow | -80 | -168 | 333 | 848 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY22 | FY23 | FY25 | FY26 |
|---|---|---|---|---|
| ROE % | – | -1.9% | 8.6% | 10.9% |
| ROCE % | – | 14.7% | 12.2% | 14.3% |
| Debtor days | – | 57 | 74 | 74 |
| Inventory days | – | 101 | 97 | 90 |
| Payable days | – | 69 | 82 | 94 |
| Cash conversion cycle (days) | – | 89 | 89 | 70 |
| Working capital days | – | 84 | 135 | 171 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 45.33% |
| FIIs | 8.90% |
| DIIs | 25.23% |
| of which Mutual funds | 13.62% |
| of which Insurance | 11.04% |
| Government | 0.00% |
| Public (non-institutions) | 20.53% |
| Quarter | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 45.17% | 45.18% | 45.18% | 45.21% | 45.22% | 45.22% | 45.33% | 45.33% |
| Promoter group | % |
|---|---|
| Aagam Holdings Private Limited | 22.60% |
| Arvind Farms Pvt Ltd | 9.50% |
| Aagam Agencies Pvt Ltd | 4.20% |
| Aayojan Resources Private Ltd | 2.10% |
| Akshita Holdings Private Limited | 1.58% |
| Adhinami Investments Private Limited | 1.55% |
| Anusandhan Investments Limited | 0.80% |
| Samvegbhai Arvindbhai Lalbhai* | 0.71% |
| Samvegbhai Arvindbhai (On behalf of Samvegbhai Arvindbhai Lalbhai HUF) | 0.39% |
| Sunil Siddharth Lalbhai | 0.32% |
| Saumya Samvegbhai Lalbhai | 0.25% |
| Swati S Lalbhai | 0.22% |
| Taral S Lalbhai | 0.18% |
| Samvegbhai Arvindbhai Lalbhai (On behalf of Ankush Trust) | 0.17% |
| Samvegbhai Arvindbhai Lalbhai (On behalf of Adwait Trust) | 0.17% |
| Public holders above 1% | % |
|---|---|
| Life Insurance Corporation Of India | 5.44% |
| Dsp Small Cap Fund | 4.73% |
| Icici Prudential Smallcap Fund | 4.51% |
| Sbi Life Insurance Co. Ltd | 3.69% |
| Aditya Birla Sun Life Mutual Fund - Aditya Birla Sun Life Flexi Cap Fund | 1.83% |
| Tata Aia Life Insurance Co Ltd Unit Linked Multi Cap Fund | 1.04% |
54,964 shareholders. Pledged: 0.97% of promoter shares.
Peers in Specialty Chemicals
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| PIDILITIND | ₹1,50,431 cr | 56.8x | 13.9x | 25.7% | 33.4% | 24.5% | +7.4% | 1.01% |
| FLUOROCHEM | ₹46,168 cr | 75.4x | 5.9x | 8.1% | 10.0% | 25.6% | -4.2% | 0.07% |
| NAVINFLUOR | ₹39,306 cr | 49.7x | 9.9x | 23.9% | 22.2% | 33.7% | +16.8% | 0.18% |
| DEEPAKNTR | ₹19,676 cr | 25.1x | 3.4x | 14.0% | 15.3% | 15.4% | -0.4% | 0.52% |
| AETHER | ₹19,529 cr | 82.8x | 8.0x | 10.1% | 11.4% | 30.9% | +21.2% | – |
| ATUL | ₹15,762 cr | 19.8x | 2.5x | 11.9% | 16.9% | 17.9% | +7.9% | 0.47% |
| AARTIIND | ₹15,539 cr | 29.3x | 2.6x | 9.2% | 8.0% | 14.9% | +7.8% | 0.24% |
| FINEORG | ₹15,328 cr | 35.0x | 5.8x | 17.7% | 21.3% | 21.7% | -7.8% | 0.22% |
| BASF | ₹13,174 cr | 20.5x | 3.3x | 16.9% | 22.0% | 5.9% | +3.1% | 0.66% |
| PRIVISCL | ₹13,109 cr | 37.5x | 9.3x | 27.6% | 22.6% | 24.9% | +16.8% | 0.15% |
Business segments (FY26)
| Segment | Revenue | Share | EBIT | Margin |
|---|---|---|---|---|
| Performance and Other Chemicals | ₹4,609 cr | 71.0% | ₹86 cr | 1.9% |
| Life Science Chemicals | ₹1,805 cr | 27.8% | ₹417 cr | 23.1% |
| Others | ₹80 cr | 1.2% | ₹12 cr | 14.7% |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2026-07-17 | Dividend | Dividend - Rs 30 Per Share |
| 2025-07-11 | Dividend | Dividend - Rs 25 Per Share |
| 2024-07-12 | Dividend | Annual General Meeting/Dividend - Rs 20 Per Share |
| 2023-11-20 | Buyback | Buy Back |
| 2023-07-14 | Dividend | Annual General Meeting/Dividend - Rs 25 Per Share |
| 2022-11-02 | Dividend | Special Interim Dividend - Rs 7.50 Per Share |
| 2022-07-14 | Dividend | Annual General Meeting/Dividend - Rs 25 Per Share |
| 2021-07-15 | Dividend | Annual General Meeting/Dividend - Rs 20 Per Share |
| 2020-03-18 | Dividend | Interim Dividend - Rs 15 Per Share |
| 2019-11-04 | Dividend | Special Dividend - Rs 12.5 Per Sh |
| 2019-07-11 | Dividend | Annual General Meeting / Dividend - Rs 15 Per Share |
| 2018-07-12 | Dividend | Dividend Rs - 12/- Per Share |
| 2017-07-13 | Dividend | Dividend - Rs 10/- Per Share |
| 2016-07-14 | Dividend | Dividend - Rs 10/- Per Share |
| 2015-06-18 | Dividend | Annual General Meeting/Dividend - Rs 8.50/- Per Share |
| 2014-06-20 | Dividend | Annual General Meeting / Dividend Rs 7.50/- Per Share |
| 2013-06-21 | Dividend | Annual General Meeting/Dividend Rs 6 Per Share |
| 2012-06-21 | Dividend | Annual General Meeting/Dividend Rs 4.50 Per Share |
| 2011-06-29 | Dividend | Annual General Meeting And Dividend Rs.4.50 Per Share |
| 2010-07-29 | Dividend | Annual General Meeting And Dividend Rs.4/- Per Share |
Documents
- Annual report FY26
- Annual report FY26
- Annual report FY25
- Annual report FY24
- Annual report FY23
- Announcements NSE filings
- BRSR FY26
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
- Life Science Chemicals: R&D, technology, procurement, manufacturing, sales and marketing
- Performance and Other Chemicals: R&D, technology, procurement, manufacturing, sales and marketing
- Others: R&D, technology, procurement, manufacturing, sales and marketing
| Sector | Commodities |
| Industry | Specialty Chemicals |
| Sub-industry | Specialty Chemicals |
| Symbol | ATUL |
| BSE code | 500027 |
| ISIN | INE100A01010 |
| Face value | ₹10.0 |
| Incorporated | 1975-12-11 |
| Website | www.atul.co.in |
| Plants (India / abroad) | 8 / 0 |
From the company's filings (BRSR FY26).
Data built 2026-10-22 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.